AMTX-100 Formulations & Pipeline
We appreciate the role of volunteers who enroll in clinical trials—with their critical participation, we are able to evaluate and advance potential new therapies that can aid in restoring the health of millions of patients.
Amytrx has begun enrollment in an adaptive Phase 1/2b clinical trial of AMTX-100 CF in the skin disease, atopic dermatitis (eczema). For more information on this study, please visit clinicaltrials.gov.
Medical professionals can visit our contact page to email a request for more information about clinical trial participation.